The groundbreaking approach of the medication represents a exciting development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide422509.losblogos.com/40697802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment